Boris Reznick, PhD

Boris Reznik is an experienced executive currently serving as Chairman and CEO of Immorta Bio, a company focused on treating diseases of aging and revolutionizing stem cell applications. Active in advisory roles for multiple emerging and microcap companies since November 2018, Boris also holds the position of Chairman at Venvalo Group, where strategic initiatives enhance value for mid-market enterprises. Additionally, Boris has been Chairman of Biorasi since 2002 and led the Vendevia Group until October 2023, focusing on value creation in biomedical technologies. Earlier in their career, Boris was Chairman of Optum Software from 1985 to 1998.